Indegene Limited IPO Detail
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.
The company's services can be divided into following categories
- Enterprise Commercial Solutions
- Omnichannel Activation
- Enterprise Medical Solutions
- Enterprise Clinical Solutions and consultancy services
The subsidiary of the company, DT Associates Limited, provides consulting services under the "DT Consulting" brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience.
The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India.
As of December 31, 2023, the company had 65 clients actively engaged with its services.
As of December 31, 2023, the company employed 5,181 people worldwide. Of these, 4,461 are based in India, 530 work in North America, 105 in Europe, 73 in China, and 12 in other regions.
Company Promoters
IPO Details
| IPO Opening Date | May 06, 2024 |
| IPO Closing Date | May 08, 2024 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹2 per equity share |
| IPO Price | ₹430 - 452 per equity share |
| Market Lot | 33 Shares |
| Min Order Quantity | 33 Shares |
| Listing At | BSE, NSE |
| Issue Size | ₹1,841.76 Cr |
| Fresh Issue | ₹760.00 Cr |
| Offer for Sale | ₹1,081.76 Cr |
| Employee Discount | ₹₹30 per share |
| Retail Portion | 35% |
IPO Subscription (Bidding Detail)
| AS On | QIB | SHNI | BHNI | NII | RII | TOTAL |
|---|---|---|---|---|---|---|
| Day 1 | 0.05x | 4.27x | 4.24x | 4.25x | 1.56x | 1.70x |
| Day 2 | 5.45x | 15.98x | 19.67x | 18.44x | 3.94x | 7.44x |
| Day 3 | 192.72x | 43.26x | 62.23x | 55.91x | 7.86x | 70.30x |
IPO Tentative Timetable
The Indegene Limited IPO open date is May 06, 2024, and the close date is May 08, 2024. The issue may list on May 13, 2024.
| IPO Open Date | May 06, 2024 |
| IPO Close Date | May 08, 2024 |
| Basis of Allotment Date | May 09, 2024 |
| Initiation of Refunds | May 10, 2024 |
| Credit of Shares to Demat Account | May 10, 2024 |
| IPO Listing Date | May 13, 2024 |
IPO Lot Size
The Indegene Limited IPO market lot size is 33 shares. A retail-individual investor can apply for up to 13 lots (429 shares or ₹193908).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 33 | ₹14916 |
| Maximum | 13 | 429 | ₹193908 |
IPO Promoter Holding
| Pre Issue Share Holding | 30.71% |
| Post Issue Share Holding |
Company Financials:
For the year/period ended (₹ in Cr.)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 596.04 | 996.92 | 149.41 |
| 31-Mar-22 | 1353.47 | 1690.50 | 162.82 |
| 31-Mar-23 | 2203.87 | 2364.10 | 266.10 |
| 31-Dec-23 | 2518.15 | 1969.75 | 241.90 |
Objects of the Issue:
The Company proposes to utilise the Net Proceeds towards funding the following objects:
- Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc.;
- Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc.; and
- General corporate purposes and inorganic growth.
Indegene Limited IPO Registrar:
Link Intime India Private Ltd
Indegene Limited IPO Lead Manager(s):
Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited J.P. Morgan India Private Limited Nomura Financial Advisory And Securities (India) Pvt Ltd
Company Contact Information:
Indegene Limited
Aspen Block G4, 3 rd Floor, Manyata Embassy
Business Park, Outer Ring Road, Nagawara
Bengaluru 560 045
